Prolonged effects of β-estradiol 3-benzoate on thyroid tumorigenesis in gonadectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine

Cancer Letters

Volumn 190, Issue 1, 2003, Pages 21-29

  Son, Hwa Young ^a,b   Nishikawa, Akiyoshi ^a   Okazaki, Kazushi ^a   Kanki, Keita ^a   Yamagishi, Megumi ^a   Imazawa, Takayoshi ^a   Umemura, Takashi ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Chungnam National University   (South Korea)

Author keywords

Estrogen; Gonadectomy; N bis(2 hydroxypropyl)nitrosamine (DHPN); Thyroid carcinogenesis

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; CHOLESTEROL; ESTRADIOL BENZOATE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLICULAR CARCINOMA; GONADECTOMY; HISTOPATHOLOGY; HYPOPHYSIS; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID GLAND; THYROID TUMOR; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UTERUS;

EID: 0037428876     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00589-X     Document Type: Article

References (40)

1. Gallagher J.C. Role of estrogens in the management of postmenopausal bone loss. Rheum. Dis. Clin. N. Am. 27:2001;143-162.
2. Hunt B.E., Taylor J.A., Hamner J.W., Gagnon M., Lipsitz L.A. Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women. Circulation. 103:2001;2909-2914.
3. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21:2000;40-54.
4. Napalkov N.P. On some new aspects of experimental carcinogenesis in thyroid gland. Acta Un. Int. Cancer. 19:1963;756-757.
5. Fujimoto N., Sakai Y., Ito A. Increase in estrogen receptor levels in MNU-induced thyroid tumors in LE rats. Carcinogenesis. 13:1992;1315-1318.
6. Mori M., Naito M., Watanabe H., Takeichi N., Dohi K., Ito A. Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. Cancer Res. 50:1990;7662-7667.
7. Furlanetto T.W., Nguyen L.Q., Jameson J.L. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology. 140:1999;5705-5711.
8. Inoue H., Oshimo K., Miki H., Kawano M., Monden Y. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma. Cancer. 72:1993;1364-1368.
9. Takagi H., Mitsumori K., Onodera H., Nasu M., Tamura T., Yasuhara K., Takegawa K., Hirose M. Modifying effects of endocrine disrupting chemicals on N-bis(2-hydroxypropyl)nitrosamine and sulfadimethoxine-induced thyroid carcinogenesis in rats. J. Toxicol. Pathol. 14:2001;121-128.
10. Takagi H., Mitsumori K., Onodera H., Nasu M., Tamura T., Yasuhara K., Takegawa K., Hirose M. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats. Cancer Lett. 178:2000;1-9.
11. Son H.Y., Nishikawa A., Ikeda T., Furukawa F., Hirose M. Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn. J. Cancer Res. 91:2000;966-972.
12. Mitsumori K., Onodera H., Takahashi M., Shimo T., Yasuhara K., Kitaura K., Takahashi M., Hayashi Y. Effect of thyroid stimulating hormone on the development and progression of rat thyroid follicular cell tumors. Cancer Lett. 92:1995;193-202.
13. Hiasa Y., Kitahori Y., Kato Y., Ohshima M., Konishi N., Shimoyama T., Sakaguchi Y., Hashimoto H., Minami S., Murata Y. Potassium perchlorate, potassium iodide, and propylthiouracil: promoting effect on the development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Jpn. J. Cancer Res. 78:1987;1335-1340.
14. Botts S., Jokinen M.P., Isaack K.R., Meuten D.J., Tanaka N. Proliferative lesions of the thyroid and parathyroid glands, E-3. Guides for Toxicologic Pathology. 1991;STP/ARP/AFIP, Washington, DC.
15. Smith M.S., Freeman M.E., Neill J. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology. 96:1975;219-226.
16. Paloyan E., Hofmann C., Prinz R.A., Oslapas R., Shah K.H., Ku W.W., Ernst K., Smith M., Lawrence A.M. Castration induces a marked reduction in the incidence of thyroid cancers. Surgery. 92:1982;839-848.
17. Farbota L., Hofmann C., Oslapas R., Paloyan E. Sex hormone modulation of serum TSH levels. Surgery. 102:1987;1081-1087.
18. Hill R.N., Erdreich L.S., Paynter O.E., Roberts P.A., Rosenthal S.L., Wilkinson C.F. Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12:1989;629-697.
19. Capen C.C. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Pathol. 25:1997;39-48.
20. Chen H.J., Walfish P.G. Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology. 103:1978;1023-1030.
21. D'Angelo S.A., Fisher J.S. Influence of estrogen on the pituitary-thyroid system of the female rat: mechanisms and loci of action. Endocrinology. 84:1969;117-222.
22. Miller W.L., Knight M.M., Gorski J. Estrogen action in vitro: regulation of thyroid stimulating and other pituitary hormones in cell cultures. Endocrinology. 101:1977;1455-1460.
23. Lisboa P.C., Curty F.H., Moreira R.M., Pazos-Moura C.C. Effects of estradiol benzoate on 5′-iodothyronine deiodinase activities in female rat anterior pituitary gland, liver and thyroid gland. Braz. J. Med. Biol. Res. 30:1997;1479-1484.
24. Nilsson M., Ericson L.E. Effects of epidermal growth factor on basolateral iodide uptake and apical iodide permeability in filter-cultured thyroid epithelium. Endocrinology. 135:1997;1428-1436.
25. Kraiem Z., Sadeh O., Yosef M., Aharon A. Mutual antagonistic interactions between the thyrotropin (adenosine 3′,5′-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles. Endocrinology. 136:1995;585-590.
26. Kotajima A., Miyamoto Y., Tsuruo M., Kosaka M., Saito S. Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology. 136:1995;1214-1218.
27. Arai M., Tsushima T., Isozaki O., Demura H., Shizume K., Emoto N., Miyakawa M., Nozoe Y., Murakami H., Ohmura E. Effects of transforming growth factor alpha (TGF-alpha) on DNA synthesis and thyrotropin-induced iodine metabolism in cultured porcine thyroid cells. Eur. J. Endocrinol. 132:1995;242-248.
28. Furlanetto T.W., Nunes R.B. Jr., Sopelsa A.M., Maciel R.M. Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells. Braz. J. Med. Biol. Res. 34:2001;259-263.
29. De Lean A., Labrie F. Sensitizing effect of treatment with estrogens on TSH response to TRH in male rats. Am. J. Physiol. 233:1977;E235-E239.
30. Shou M., Korzekwa K.R., Brooks E.N., Krausz K.W., Gonzalez F.J., Gelboin H.V. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis. 18:1997;207-214.
31. Miki H., Oshimo K., Inoue H., Morimoto T., Monden Y. Sex hormone receptors in human thyroid tissues. Cancer. 66:1990;1759-1762.
32. Hiasa Y., Nishioka H., Kitahori Y., Yane K., Nakaoka S., Ohshima M., Konishi N., Nishii K., Kitamura M., Sugimura M. Immunohistochemical detection of estrogen receptors in paraffin sections of human thyroid tissues. Oncology. 48:1991;421-424.
33. Yane K., Kitahori Y., Konishi N., Okaichi K., Ohnishi T., Miyahara H., Matsunaga T., Lin J.C., Hiasa Y. Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett. 84:1994;59-66.
34. Jaklic B.R., Rushin J., Ghosh B.C. Estrogen and progesterone receptors in thyroid lesions. Ann. Surg. Oncol. 2:1995;429-434.
35. Diaz N.M., Mazoujian G., Wick M.R. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Arch. Pathol. Lab. Med. 115:1991;1203-1207.
36. Lee C., Kao H., Lin H., P'eng F., Chi C. Estrogen receptors and glucocorticoid receptors in human well-differentiated thyroid cancer. Int. J. Mol. Med. 2:1998;229-233.
37. Vidal S., Cameselle-Teijeiro J., Horvath E., Kovacs K., Bartke A. Effect of protracted estrogen administration on the thyroid of Ames dwarf mice. Cell Tissue Res. 304:2001;51-58.
38. Wang S.H., Myc A., Koenig R.J., Bretz J.D., Arscott P.L., Baker J.R. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis. Mol. Cell Endocrinol. 165:2000;163-172.
39. Liehr J.G., Roy D., Ari-Ulubelen A., Bui Q.D., Weisz J., Strobel H.W. Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: implications for carcinogenesis. J. Steroid Biochem. 35:1990;555-560.
40. Machishi H., Higashi S., Hibasami H., Nakashima K., Kawarada Y., Mizumoto R. Role of activation of ornithine decarboxylase and DNA synthesis on ethynylestradiol-induced hepatocarcinogenesis. Carcinogenesis. 16:1995;2965-2971.